Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Medical Center
With
National Institute on Drug Abuse (NIDA)
Age
15–24
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female age 15 to 24
Meet DSM-5 criteria for a substance use disorder
Substance use ≥ 14 days of past 28 days (i.e. use ≥ 50% of days in the past 28 days)
If subject in restricted setting/care (e.g. inpatient detox unit or residential treatment) for ≤ 2 weeks, then use ≥ 50% of days while outside of restricted setting (e.g. 7 days of substance use out of 14 days in unrestricted setting)
Subjects need to have been in an unrestricted setting for at least 2 weeks prior to screening
Meets DSM-5 criteria for bipolar disorder or disruptive mood dysregulation disorder or DSM IV criteria for mood disorder not otherwise specified
Symptoms of SMD: Youth Self Report (YSR) or Adult Self Report (ASR) AAA ≥180
Stable to be treated in outpatient level of care
You may not be if
Current methamphetamine use disorder
Current unstable opioid use disorder (i.e. \< 3 months on medication assisted treatment for an opioid use disorder)
Pregnant or breastfeeding
Placement in a restricted setting (e.g. detox or residential treatment) for ≥ 2 weeks out of past 28 days prior to screening visit, or placement in a restricted setting at anytime during study participation
Unwilling or unable to use effective birth control
Unwilling or unable to sign release of information for the treatment program providing behavioral treatment
For participants \>17 years-unable or unwilling to identify emergency contact
Clareo Health | Treatment With Quetiapine for Youth With Substance Use Disorders and Severe Mood Dysregulation
